4//SEC Filing
Grunwald Alf 4
Accession 0000950170-25-056359
CIK 0001531978other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:00 PM ET
Size
6.0 KB
Accession
0000950170-25-056359
Insider Transaction Report
Form 4
Grunwald Alf
Director
Transactions
- Disposition to Issuer
Common Stock
2025-04-21−51,935→ 0 total
Footnotes (3)
- [F1]In connection with the terms of an Agreement and Plan of Merger, dated January 28, 2025 (the "Merger Agreement"), by and among the Issuer, Zimmer Biomet Holdings, Inc., Zimmer, Inc. ("Parent"), and Gazelle Merger Sub I, Inc., a wholly owned subsidiary of Parent ("Merger Sub"), Merger Sub merged with and into the Issuer, with the Issuer continuing as the surviving corporation and a wholly owned subsidiary of Parent upon consummation of the merger (the "Effective Time").
- [F2]At the Effective Time, each outstanding share of Common Stock was automatically converted into the right to receive (i) $13.00 in cash, without interest (the "Cash Consideration") and (ii) one contractual contingent value right ("CVR") per share representing the right to receive a contingent payment of up to $1.00 in cash upon achievement of specified milestones, as specified further in the CVR Agreement, by and among Parent, Equiniti Trust Company, LLC, as rights agent, and, for certain provisions, Zimmer Biomet Holdings, Inc., as guarantor.
- [F3]At the Effective Time, each outstanding restricted stock unit solely subject to time-based vesting conditions and vested and was canceled, with the holder thereof entitled to receive, with respect to each share of Common Stock underlying such award, (x) the Cash Consideration and (y) one CVR.
Documents
Issuer
Paragon 28, Inc.
CIK 0001531978
Entity typeother
Related Parties
1- filerCIK 0001887910
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:00 PM ET
- Size
- 6.0 KB